Corporate News     09-Aug-21
Board of Astrazeneca Pharma India recommends interim dividend
Of Rs 2 per share
Astrazeneca Pharma India announced that the Board of Directors of the Company at its meeting held on 9 August 2021, inter alia, have recommended the interim dividend of Rs 2 per equity Share (i.e. 100%) , subject to the approval of the shareholders.
Previous News
  Astrazeneca Pharma India standalone net profit rises 96.78% in the June 2022 quarter
 ( Results - Announcements 08-Aug-22   14:55 )
  AstraZeneca Pharma slumps after Q3 PAT slides 46% YoY to Rs 16 cr
 ( Hot Pursuit - 09-Feb-24   10:32 )
  AstraZeneca Pharma gets DCGI nod for breast cancer drug
 ( Hot Pursuit - 22-Aug-22   11:11 )
  Astrazeneca Pharma rises on planning to launch Enhertu
 ( Hot Pursuit - 21-Dec-23   10:01 )
  Astrazeneca Pharma India schedules board meeting
 ( Corporate News - 25-May-23   15:01 )
  Astrazeneca Pharma India schedules AGM
 ( Corporate News - 25-Jul-23   09:45 )
  Astrazeneca Pharma India standalone net profit declines 45.03% in the June 2021 quarter
 ( Results - Announcements 09-Aug-21   15:05 )
  Astrazeneca Pharma India standalone net profit declines 54.63% in the September 2021 quarter
 ( Results - Announcements 10-Nov-21   08:11 )
  Astrazeneca Pharma India standalone net profit rises 167.30% in the June 2023 quarter
 ( Results - Announcements 14-Aug-23   14:37 )
  Astrazeneca Pharma India to table results
 ( Corporate News - 31-Oct-23   14:03 )
  AstraZeneca Pharma drops after UK parent pauses COVID-19 vaccine trial
 ( Hot Pursuit - 09-Sep-20   09:37 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top